Pharmaceuticals
3 High-Yield Dividend Stocks With an International Flavor
BP, Novartis and British American Tobacco offer healthy payouts that look secure for years to come.
A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players
To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.
Cassava Sciences Is in Bad Shape, Says the Chart Doctor
As the name falls on news related to its Alzheimer's treatment under clinical study, we take a look at the technicals.
Biohaven Pharmaceutical Is Ready to Climb Higher on the Charts
Continue to hold previously recommended longs.
Would-Be Buyers Should Wait for a Dip in Bullish Prothena
The shares of the under-the-radar biotech have had a strong run in recent months, so traders might want to watch for a pullback to buy.
Staying Smaller and Tighter With This GoodRx Trade
I'm focusing on the active consumers and subscription plans as it gives us a view of the future.
Jim Cramer: Why Hasn't the Government Pushed for Mass Vaccination?
Incompetence, omissions and even outright lies have categorized this federal attempt to 'stem' the pandemic.
Jim Cramer: This Rally Is Squarely on Pfizer's Comirnaty
This COVID-19 vaccine is the potential savior of more than just the market.
Technical Problems, Stinky Breadth, Fiscal-Monetary Ying Yang, White House Shots
Plus, checking out trades related to Amazon, Macy's and a few defense and metals stocks.
Pfizer's Charts Suggest a Strong Rally Ahead
Here are our latest price targets.